Dss, inc. announces filing of registration statement on form s-1 for initial public offering of impact biomedical

New york, oct. 23, 2023 (globe newswire) -- dss, inc.(nyse american: dss) ("dss") announced today that it has filed a registration statement on form s-1 with the u.s. securities and exchange commission ("sec") relating to the proposed initial public offering of the company's wholly-owned subsidiary, impact biomedical (hyperlink: https://www.impactbiomedinc.com/). dss, inc. intends to list impact biomedical on the nyse american exchange. the number of shares of class a common stock to be offered and the price range for the proposed offering have not yet been determined. the offering is subject to market conditions.
DSS Ratings Summary
DSS Quant Ranking